Direct-Acting Oral Anticoagulants and Their Reversal Agents—An Update
<b>Background:</b> Over the last ten years, a new class of drugs, known as the direct-acting oral anticoagulants (DOACs), have emerged at the forefront of anticoagulation therapy. Like the older generation anticoagulants, DOACs require specific reversal agents in cases of life-threatenin...
Main Authors: | Stephanie A. Kustos, Pius S. Fasinu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-10-01
|
Series: | Medicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2305-6320/6/4/103 |
Similar Items
-
Non-Vitamin K Oral Anticoagulants Associated Bleeding and Its Antidotes
by: Thorsten Steiner, et al.
Published: (2018-09-01) -
Direct oral anticoagulants: A new chapter in anticoagulation therapy
by: Stepanović-Petrović Radica, et al.
Published: (2020-01-01) -
Pharmacology of new oral anticoagulants: mechanism of action, pharmacokinetics, pharmacodynamics
by: Luca Masotti, et al.
Published: (2013-12-01) -
The Clinical Significance of Drug–Food Interactions of Direct Oral Anticoagulants
by: Grzegorz Grześk, et al.
Published: (2021-08-01) -
PHARMACOGENETIC ASPECTS OF NEW ORAL ANTICOAGULANTS APPLICATION
by: A. V. Kryukov, et al.
Published: (2017-07-01)